Prednisolone in Infantile Spasms- High Dose Versus Usual Dose
NCT01575639
Brain Diseases, Central Nervous System Diseases
New Delhi, National Capital Territory of Delhi, India
View Trial DetailsNCT Number: NCT02885389
Infantile Spasms syndrome (ISs) is a characterized by epileptic spasms occurring in clusters with an onset in the first year of life. West syndrome represents a subset of ISs that associates spasms in clusters, a hypsarrhythmia EEG pattern and a developmental arrest or regression. Aetiology of ISs is widely heterogeneous including many genetic causes. Many patients, however, remain without etiological diagnosis, which is critical for prognostic purpose and genetic counselling. In the present study, the investigators performed genetic screening of 73 patients with different types of ISs by array-CGH and molecular analysis of 5 genes: CDKL5, STXBP1, KCNQ2, and GRIN2A, whose mutations cause different types of epileptic encephalopathies, including ISs, as well as MAGI2, which was suggested to be related to a subset of ISs.
Looking for future studies?
Notify Me3 month–15 year
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Day one
Hospices Civils de Lyon
Other
Molecular Characterization of a Cohort of 73 Patients With Infantile Spasms Syndrome
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01575639
Brain Diseases, Central Nervous System Diseases
New Delhi, National Capital Territory of Delhi, India
View Trial DetailsNCT06819670
Brain Diseases, Central Nervous System Diseases
Los Angeles, California, United States
View Trial DetailsNCT06315829
Brain Diseases, Central Nervous System Diseases
Baltimore, Maryland, United States
View Trial DetailsNCT00441896
Brain Diseases, Central Nervous System Diseases
Los Angeles, California, United States
View Trial Details